January 18, 2022
Johnson & Johnson on Friday said it had agreed to pay $44 million to resolve claims that it fueled the opioid epidemic in New Mexico, a state which originally opted against participating in a nationwide settlement resolving thousands of similar …
October 1, 2021
A California judge on Thursday said several large counties accusing four drugmakers of fueling an opioid epidemic had presented a “dearth of evidence” during a multi-billion dollar trial to support finding the companies’ pain pill marketing caused the health crisis. …
June 11, 2020
New York state filed civil charges on Wednesday accusing Endo International Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, adding fuel to the nation’s opioid crisis. Governor Andrew Cuomo said the charges brought by …
February 26, 2020
Opioid makers and distributors who proposed paying almost $50 billion to resolve U.S. lawsuits over the addictive drugs are drawing more support from states, including California and New York, as pressure mounts for a deal before a trial starts next …
September 13, 2019
A judge approved a bid by U.S. cities and counties suing opioid makers such as Johnson & Johnson and Teva Pharmaceutical Industries Ltd. to negotiate a settlement as a group, in an effort to resolve the sweeping litigation over the …
August 28, 2019
The Sackler family and their embattled drugmaker, Purdue Pharma LP, are backing a proposal to resolve all opioid lawsuits against themselves and the company for more than $11 billion in what would be the largest settlement to date in the …
August 27, 2019
Johnson & Johnson shares rose as much as 5.4% after an Oklahoma judge ordered the company to pay far less than some investors expected in the first trial by a state seeking compensation for the public-health crisis spawned by opioid …
August 1, 2019
Oklahoma’s attorney general on Wednesday made his final bid to force Johnson & Johnson to pay $17 billion for its part in fueling the opioid epidemic, saying the drugmaker’s “egregious” marketing caused an oversupply of addictive drugs and overdose deaths. …
June 7, 2019
Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to settle U.S. claims that the drug maker illegally sold opioid-based painkillers. Under terms of the deal, Insys …
May 29, 2019
Johnson & Johnson’s greed for more sales of its addictive opioid painkillers helped create a deadly epidemic in Oklahoma that claimed thousands of lives, and the company should pay billions of dollars as compensation, the state’s top law-enforcement officer told …